Rain Fog/Mist 37°
Tag:

University of Oxford

News
COVID-19: Mild Cases Can Cause Memory Issues Months After Infection, Brand-New Study Finds COVID-19: Mild Cases Can Cause Memory Issues Months After Infection, Brand-New Study Finds
Covid-19: Mild Cases Can Cause Memory Issues Months After Infection, Brand-New Study Finds A new study has found that those who experienced mild COVID-19 can still suffer from attention and memory deficits for months after recovering. The University of Oxford reported that participants in the study completed memory and cognitive ability tests, with a focus on cognitive functions that are important for daily life. The researchers compared the results of participants who had previously had COVID-19 to those who hadn't. The study found that those who had previously had COVID-19 performed well in most abilities, including working memory and planning, but had "significantly worse epi…

SHARE

by Nicole Valinote
News
COVID-19: Study Shows Chance Of Winter Surge That Could Be Worse Than Delta Variant COVID-19: Study Shows Chance Of Winter Surge That Could Be Worse Than Delta Variant
Covid-19: Study Shows Chance Of Winter Surge That Could Be Worse Than Delta Variant With the weather cooling down and crowded indoor holiday season gatherings fast approaching, a new study is showing that there could be a winter surge of COVID-19 cases that could rival the earlier emergence of the Delta variant. According to a newly released study, researchers are predicting that there is at least a 30 percent chance that states could experience a surge of new infections that could exceed the numbers seen during the spike in cases in mid-September during the variant. With activities moving indoors, there is expected to be a surge in cases, though with more Americans getti…

SHARE

by Zak Failla
News
COVID-19: Here's What We Know Now About Three Virus Strains CDC Calls 'Variants Of Concern' COVID-19: Here's What We Know Now About Three Virus Strains CDC Calls 'Variants Of Concern'
Covid-19: Here's What We Know Now About Three Virus Strains CDC Calls 'Variants Of Concern' As millions more American receive the COVID-19 vaccine each day, the key question now in the now more than year-long battle against the novel coronavirus comes down to this: Do the three approved vaccines being administered in the United States work against the new strains of the virus that have been confirmed, especially the highly contagious Brazil, United Kingdom, and South Africa variants? As of now, the answer is unclear because the variants first surfaced in the United States either in late December 2020 or in January 2021. "So far, studies suggest that antibodies generated through v…

SHARE

by Joe Lombardi
News
COVID-19: First Case Of Highly Contagious Brazil Strain Confirmed In NY COVID-19: First Case Of Highly Contagious Brazil Strain Confirmed In NY
Covid-19: First Case Of Highly Contagious Brazil Strain Confirmed In NY The first case of the highly contagious COVID-19 Brazilian variant has been confirmed in a New York State resident.  The case of the strain, officially known as the P.1 variant, was identified by scientists at Mount Sinai hospital in New York City and verified by the Department of Health's Wadsworth Center Laboratories.  The patient is a Brooklyn resident over age 90 with no recent travel history. DOH is working with the New York City Department of Health and Mental Hygiene to learn more information about the patient and potential contacts. "This is a race between the vaccine an…

SHARE

by Joe Lombardi
News
COVID-19: Low-Cost Steroid Dramatically Reduces Fatalities, 6,000-Patient Trial Shows COVID-19: Low-Cost Steroid Dramatically Reduces Fatalities, 6,000-Patient Trial Shows
Covid-19: Low-Cost Steroid Dramatically Reduces Fatalities, 6,000-Patient Trial Shows Scientists may be on the verge of a novel coronavirus (COVID-19) breakthrough after discovering a low-cost drug they say is the first to reduce virus-related fatalities for patients on oxygen. After successfully carrying out a 6,000-patient trial, scientists found Dexamethasone -- a well-known, inexpensive steroid -- dramatically helped those with severe cases of the virus, the scientists at the University of Oxford in England announced. One-third of the patients in the trial that were receiving ventilation had a reduced death rate, as did the one-fifth of patients on oxygen when …

SHARE

by Valerie Musson